These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24396272)

  • 1. Will global transcriptome analysis allow the detection of novel prognostic markers in coronary artery disease and heart failure?
    Gora M; Kiliszek M; Burzynska B
    Curr Genomics; 2013 Sep; 14(6):388-96. PubMed ID: 24396272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Selected miRNAs as Diagnostic and Prognostic Biomarkers in Cardiovascular Diseases, Including Coronary Artery Disease, Myocardial Infarction and Atherosclerosis.
    Mir R; Elfaki I; Khullar N; Waza AA; Jha C; Mir MM; Nisa S; Mohammad B; Mir TA; Maqbool M; Barnawi J; Albalawi SO; Abu-Duhier FM
    J Cardiovasc Dev Dis; 2021 Feb; 8(2):. PubMed ID: 33669699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profiling of cardiovascular disease.
    Archacki S; Wang Q
    Hum Genomics; 2004 Aug; 1(5):355-70. PubMed ID: 15588496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next generation MicroRNA sequencing to identify coronary artery disease patients at risk of recurrent myocardial infarction.
    Kanuri SH; Ipe J; Kassab K; Gao H; Liu Y; Skaar TC; Kreutz RP
    Atherosclerosis; 2018 Nov; 278():232-239. PubMed ID: 30336307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Troponin elevation pattern and subsequent cardiac and non-cardiac outcomes: Implementing the Fourth Universal Definition of Myocardial Infarction and high-sensitivity troponin at a population level.
    Chuang AM; Nguyen MT; Khan E; Jones D; Horsfall M; Lehman S; Smilowitz NR; Lambrakis K; Than M; Vaile J; Sinhal A; French JK; Chew DP
    PLoS One; 2021; 16(3):e0248289. PubMed ID: 33711079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherosclerotic Burden and Heart Failure After Myocardial Infarction.
    Gerber Y; Weston SA; Enriquez-Sarano M; Manemann SM; Chamberlain AM; Jiang R; Roger VL
    JAMA Cardiol; 2016 May; 1(2):156-62. PubMed ID: 27437886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease.
    Winkelmann BR; März W; Boehm BO; Zotz R; Hager J; Hellstern P; Senges J;
    Pharmacogenomics; 2001 Feb; 2(1 Suppl 1):S1-73. PubMed ID: 11258203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying differential miR and gene consensus patterns in peripheral blood of patients with cardiovascular diseases from literature data.
    Šatrauskienė A; Navickas R; Laucevičius A; Huber HJ
    BMC Cardiovasc Disord; 2017 Jun; 17(1):173. PubMed ID: 28666417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization.
    Taqueti VR; Hachamovitch R; Murthy VL; Naya M; Foster CR; Hainer J; Dorbala S; Blankstein R; Di Carli MF
    Circulation; 2015 Jan; 131(1):19-27. PubMed ID: 25400060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prioritizing Candidates of Post-Myocardial Infarction Heart Failure Using Plasma Proteomics and Single-Cell Transcriptomics.
    Chan MY; Efthymios M; Tan SH; Pickering JW; Troughton R; Pemberton C; Ho HH; Prabath JF; Drum CL; Ling LH; Soo WM; Chai SC; Fong A; Oon YY; Loh JP; Lee CH; Foo RSY; Ackers-Johnson MA; Pilbrow A; Richards AM
    Circulation; 2020 Oct; 142(15):1408-1421. PubMed ID: 32885678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis in relation to high-sensitivity cardiac troponin T levels in patients with myocardial infarction and non-obstructive coronary arteries.
    Hjort M; Lindahl B; Baron T; Jernberg T; Tornvall P; Eggers KM
    Am Heart J; 2018 Jun; 200():60-66. PubMed ID: 29898850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac magnetic resonance imaging findings and the risk of cardiovascular events in patients with recent myocardial infarction or suspected or known coronary artery disease: a systematic review of prognostic studies.
    El Aidi H; Adams A; Moons KG; Den Ruijter HM; Mali WP; Doevendans PA; Nagel E; Schalla S; Bots ML; Leiner T
    J Am Coll Cardiol; 2014 Mar; 63(11):1031-45. PubMed ID: 24486280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure.
    Ivanes F; Susen S; Mouquet F; Pigny P; Cuilleret F; Sautière K; Collet JP; Beygui F; Hennache B; Ennezat PV; Juthier F; Richard F; Dallongeville J; Hillaert MA; Doevendans PA; Jude B; Bertrand M; Montalescot G; Van Belle E
    Eur Heart J; 2012 Jan; 33(2):191-202. PubMed ID: 21719456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers in acute myocardial infarction.
    Chan D; Ng LL
    BMC Med; 2010 Jun; 8():34. PubMed ID: 20529285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of ventricular fibrillation, acute myocardial infarction (myocardial necrosis), heart failure, and mortality by bretylium: is ischemic heart disease primarily adrenergic cardiovascular disease?
    Bacaner M; Brietenbucher J; LaBree J
    Am J Ther; 2004; 11(5):366-411. PubMed ID: 15356432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation and future risk of symptomatic heart failure in patients with stable coronary artery disease.
    Eisen A; Benderly M; Behar S; Goldbourt U; Haim M
    Am Heart J; 2014 May; 167(5):707-14. PubMed ID: 24766981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidetector computed tomography for coronary artery disease screening in asymptomatic populations: evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(3):1-56. PubMed ID: 23074503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.